Insulinoma

• Insulinoma is a rare, usually benign, tumor of the pancreas that secretes excessive insulin.
• The primary symptom is hypoglycemia, leading to neuroglycopenic and adrenergic effects.
• Diagnosis involves a supervised fasting test and imaging studies to locate the tumor.
• Surgical removal is the most effective treatment, often leading to a cure.
• Medical management is available for patients who are not candidates for surgery.

What is Insulinoma?

Insulinoma refers to a rare neuroendocrine tumor that develops in the pancreas, specifically from the beta cells of the islets of Langerhans. These tumors are characterized by their uncontrolled secretion of insulin, irrespective of the body’s blood glucose levels. This persistent overproduction of insulin leads to recurrent episodes of hypoglycemia, a condition where blood sugar levels drop dangerously low. While most insulinomas are benign (non-cancerous) and solitary, approximately 10% can be malignant (cancerous) or occur as multiple tumors. The incidence of insulinoma is estimated to be about 1 to 4 cases per million people per year, making it one of the rarest pancreatic tumors. (Source: National Institutes of Health, NIDDK). Understanding what is Insulinoma is crucial for recognizing its unique physiological impact and the challenges it presents in diagnosis and management.

Insulinoma Symptoms and Causes

The clinical manifestations of insulinoma symptoms causes primarily stem from the persistent hypoglycemia induced by the tumor’s excessive insulin secretion. When blood glucose levels fall too low, the brain, which relies heavily on glucose for energy, can become impaired, leading to neuroglycopenic symptoms. Additionally, the body releases counter-regulatory hormones like adrenaline, causing adrenergic symptoms.

Common symptoms include:

• Sweating and tremors
• Heart palpitations
• Weakness and fatigue
• Intense hunger
• Dizziness and confusion
• Blurred vision
• Difficulty concentrating
• Behavioral changes, such as irritability or aggression
• Seizures or loss of consciousness in severe cases

These symptoms often occur when a person has gone without food for several hours, such as overnight or before meals, and are typically relieved by eating or consuming sugar. The exact causes of insulinoma are largely unknown in most cases, with the majority occurring sporadically without a clear genetic predisposition. However, a small percentage of insulinomas are associated with inherited conditions, most notably Multiple Endocrine Neoplasia type 1 (MEN1) syndrome, which involves tumors in multiple endocrine glands.

Diagnosing and Treating Insulinoma

Accurate diagnosing insulinoma requires a combination of clinical suspicion, biochemical tests, and imaging studies. The cornerstone of diagnosis is the supervised 72-hour fasting test, during which blood glucose and insulin levels are monitored. In patients with insulinoma, this test typically reveals low blood glucose levels accompanied by inappropriately high insulin and C-peptide levels. Once biochemical confirmation is achieved, localization studies are performed to identify the tumor’s exact position within the pancreas. These may include Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI), or Endoscopic Ultrasound (EUS), which is highly sensitive for detecting small tumors. More invasive procedures like arterial stimulation and venous sampling (ASVS) may be used to pinpoint the tumor’s location by measuring insulin levels in blood samples from pancreatic veins after arterial stimulation.

The primary goal of insulinoma treatment options is to remove the tumor and alleviate the symptoms of hypoglycemia. Surgical resection is the most effective and often curative treatment. The specific surgical approach depends on the tumor’s size and location, ranging from enucleation (removing only the tumor) to partial pancreatectomy (removing part of the pancreas). For patients who are not surgical candidates due to comorbidities or in cases of malignant or metastatic insulinoma, medical management aims to control hypoglycemia. This can involve medications such as diazoxide, which inhibits insulin release, or somatostatin analogs, which can reduce hormone secretion and tumor growth. Dietary modifications, including frequent small meals and complex carbohydrates, also play a supportive role in managing blood sugar fluctuations.